Sarcopenia Treatment Market 2023 Updates : Rise in R&D activities for the treatment of sarcopenia projected to register a CAGR of 6.1%, Claims AMR

Sarcopenia is a medical condition that involves the loss of skeletal muscle mass and function. While it is commonly associated with the aging population, it can also occur in individuals who have certain conditions that are not exclusive to older individuals. The condition is characterized by symptoms such as a decrease in muscle mass, weakness, and reduced stamina, which can have a significant impact on physical activity levels. Furthermore, reduced physical activity can exacerbate muscle shrinkage.

Request Report Sample – https://www.alliedmarketresearch.com/request-sample/10891

In 2020, Asia-Pacific dominated the market for sarcopenia treatment and held the largest revenue share in 2020, highest growth rate majorly due to changing lifestyle conditions, increasing geriatric population, and increasing healthcare facilities. Furthermore, increase in R&D activities for development of novel therapies and rise in prevalence of the sarcopenia disease will further boost the growth of the sarcopenia treatment market in the region during the forecast period.

Procure Complete Report (239 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/sarcopenia-treatment-market/purchase-options

Impact of Covid-19 on Sarcopenia Treatment Market-

• The COVID-19 pandemic is anticipated to positively impact the sarcopenia treatment market.
• As sarcopenia patients are more exposed to Covid-19 infection, the pandemic has caused a many sarcopenia cases, especially in the elder population.
• Lockdown and uncertain food delivery chain led to unavailability of protein-rich and other nutritional food items. This affected the overall health of people and led to muscle loss and other muscle disorders in people suffering from other health conditions.

Have Any Query? Ask Our Expert @:  https://www.alliedmarketresearch.com/purchase-enquiry/10891

Key Findings Of The Study

• By treatment, the protein supplement segment witnessed the highest growth with a CAGR of 5.9% in the global sarcopenia treatment market in 2020.
• By route of administration, the oral segment held the largest market share in 2020 and is expected to remain dominant throughout the forecast period.
• By distribution channel, the hospital pharmacies segment exhibits the fastest growth and is expected to grow at a CAGR of 5.5% from 2021 to 2030.
• By region, Asia-Pacific is expected to experience a growth at the highest rate, registering a CAGR of 7.5% during the forecast period.

Other Top Reports –

Gloves Market–  https://www.alliedmarketresearch.com/gloves-market-A08867

Oligonucleotide Synthesis Market – https://www.alliedmarketresearch.com/oligonucleotide-synthesis-market-A08356

Influenza Treatment Market –https://www.alliedmarketresearch.com/influenza-treatment-market-A06106